Call now: 866-878-7812

Contact Us  Find a Clinic

  • Achieve Weight Loss
  • main-banner-app
  • main-banner1
  • Successful Weight Loss System
  • Minimally Invasive Weight Loss

how-it-works-button

app-button

Calculate Your BMI

Take the next step to see if you may be eligible for the LAP-BAND® System by calculating your BMI.

More than 800,000 people have received a LAP-BAND® worldwide1

The LAP-BAND AP® Adjustable Gastric Banding System is designed to induce weight loss by limiting food consumption. No cutting or stapling of the stomach is required, and there is no bypassing of portions of the stomach or intestines.

Weight loss associated with the LAP-BAND® System has been shown to improve or lead to remission of type 2 diabetes in patients with BMI greater than or equal to 35.2

how-it-works-button

app-button

Important LAP-BAND® System Safety Information

Indications: The LAP-BAND® System is indicated for weight reduction for patients, with a Body Mass Index (BMI) of at least 35 kg/m2 or a BMI of at least 30 kg/m2 with one or more weight-related comorbid conditions. It is indicated for use only in adult patients who have failed more conservative weight reduction alternatives, such as supervised diet, exercise and behavior modification programs. Patients who elect to have this surgery must make the commitment to accept significant changes in their eating habits for the rest of their lives.

Contraindications: The LAP-BAND® System is not recommended for non-adult patients, patients with conditions that may make them poor surgical candidates or increase the risk of poor results (e.g., inflammatory or cardiopulmonary diseases, GI conditions, symptoms or family history of autoimmune disease, cirrhosis), who are unwilling or unable to comply with the required dietary restrictions, who have alcohol or drug addictions, or who currently are or may be pregnant.

Warnings: The LAP-BAND® System is a long-term implant. Explant and replacement surgery may be required. Patients who become pregnant or severely ill, or who require more extensive nutrition may require deflation of their bands. Anti-inflammatory agents, such as aspirin, should be used with caution and may contribute to an increased risk of band erosion.

Adverse Events: Placement of the LAP-BAND® System is major surgery and, as with any surgery, death can occur. Possible complications include the risks associated with the medications and methods used during surgery, the risks associated with any surgical procedure, and the patient’s ability to tolerate a foreign object implanted in the body. Band slippage, erosion and deflation, reflux, obstruction of the stomach, dilation of the esophagus, infection, or nausea and vomiting may occur. Reoperation may be required. Rapid weight loss may result in complications that may require additional surgery. Deflation of the band may alleviate excessively rapid weight loss or esophageal dilation.

Important: For full safety information please click here, talk with your doctor, or call Apollo Customer Support at 1-866-878-7812.

CAUTION: Rx only.

*Patients shown here are LAP-BAND® System patients who were treated in the United States. Results are from individual customer testimonials and your results may vary.

MKT-00661-01R02

1 Apollo Endosurgery MMO-00220-00.
2 Dixon JB, et al., Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes: A Randomized Controlled Trial, JAMA 2008;299(3):316-323.